Back to search results

Pectoralis Minor Release in Reverse Total Shoulder Arthroplasty

This study is looking at whether releasing a muscle called the pectoralis minor (located in your chest) during Reverse Total Shoulder Arthroplasty (RSA) surgery can improve pain and other outcomes. RSA is a common surgery for severe shoulder arthritis or rotator cuff tears. You could be eligible if you are an adult (18 years or older) having RSA surgery for these conditions and are able to give informed consent. The study aims to see if releasing the pectoralis minor leads to less pain, better movement in your arm, and improved patient-reported outcomes after surgery. Participants will be randomly assigned to either have the pectoralis minor released during their RSA surgery or not.

Study design
This interventional study plans to enroll 90 participants. Participants will be randomly assigned to receive either RSA with pectoralis minor release or RSA without pectoralis minor release.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Pain scores will be measured at baseline and 6 months after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06292169

Pectoralis Minor Release Versus Non-release in RSA

Recruiting
NAAges 18+InterventionalTreatment
Emory University
~90 participants
Updated 2025-10-23 on ClinicalTrials.gov
What's tested:Pectoralis Minor ReleaseRSA

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Visual analog Scale (VAS) pain scores
Measured over Baseline, 6 months

Conditions

Reverse Total Shoulder Arthroplasty
Rotator Cuff Tear Arthropathy
Advanced Glenohumeral Osteoarthritis

Explore related trials

Osteoarthritis of glenohumeral jointRotator cuff tear arthropathy

NCT06292169

Where you'd take part

This study runs at 2 sites. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • Emory Clinic

    Atlanta, Georgiastudy coordinator listed

    Recruiting

  • Emory Healthcare Orthopaedics and Spine Center

    Atlanta, Georgiastudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Eric Wagner, MD · PRINCIPAL_INVESTIGATOR · Emory University

Who to contact

Eric Wagner, MD
[email protected]
404-778-7249
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

All patients undergoing surgery for reverse total shoulder arthroplasty
Patients willing and able to provide informed consent

Exclusion

Revision arthroplasty
Reverse shoulder arthroplasty for proximal humerus fractures
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Pregnant women
Prisoners

What this trial measures

  • Visual analog Scale (VAS) pain scoresBaseline, 6 months

    The Visual Analogue Scale (VAS) measures pain intensity. The VAS consists of a 10cm line, with two end points representing 0 ('no pain') and 10 ('pain as bad as it could possibly be'). Study participants will be asked to rate their current level of pain by placing a mark on the line